Back to Search
Start Over
Supplementary Table 3 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file, 361K, Comparison of EGFR TKI and HSP90 inhibitor efficacy in Ba/F3 cells ectopically expressing different EGFR mutations.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1786c91a1f98aabb40c79a7aec6b396d
- Full Text :
- https://doi.org/10.1158/1078-0432.22443380